Cargando…
Protective Effects of Astragaloside IV against Amyloid Beta1-42 Neurotoxicity by Inhibiting the Mitochondrial Permeability Transition Pore Opening
Mitochondrial dysfunction caused by amyloid β-peptide (Aβ) plays an important role in the pathogenesis of Alzheimer disease (AD). Substantial evidence has indicated that the mitochondrial permeability transition pore (mPTP) opening is involved in Aβ-induced neuronal death and reactive oxygen species...
Autores principales: | Sun, Qinru, Jia, Ning, Wang, Weixi, Jin, Hui, Xu, Jiehua, Hu, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048237/ https://www.ncbi.nlm.nih.gov/pubmed/24905226 http://dx.doi.org/10.1371/journal.pone.0098866 |
Ejemplares similares
-
Astragaloside IV Inhibits Oxidative Stress-Induced Mitochondrial Permeability Transition Pore Opening by Inactivating GSK-3β via Nitric Oxide in H9c2 Cardiac Cells
por: He, Yonggui, et al.
Publicado: (2012) -
Dual dynamics of mitochondrial permeability transition pore opening
por: Wacquier, Benjamin, et al.
Publicado: (2020) -
Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
por: Xu, Jingyu, et al.
Publicado: (2021) -
Hyperoside protects the blood-brain barrier from neurotoxicity of amyloid beta 1–42
por: Liu, Chen-Yang, et al.
Publicado: (2018) -
Grape seed proanthocyanidins ameliorate neuronal oxidative damage by inhibiting GSK-3β-dependent mitochondrial permeability transition pore opening in an experimental model of sporadic Alzheimer’s disease
por: Sun, Qinru, et al.
Publicado: (2019)